Inhibition of autophagy, either through 3-methyladenine treatment or knockdown of Beclin-1 or Atg12, significantly reduces the ability of human embryonic kidney cells (HEK293T) and malignant melanoma cells to present model antigen OVA or endogenous tumor antigens (229). Here, ATG12 is linked to neoplasm.